期刊文献+

含硫(硒)醚羟喜树碱衍生物的合成及体外抗肿瘤活性初步研究

Synthesis and evaluation of hydroxycamptothecin derivatives containing S(Se) bonds
原文传递
导出
摘要 目的 设计合成几种含硫(硒)醚键的羟喜树碱衍生物,并进行体外抗肿瘤活性筛选。方法 以天然产物羟喜树碱为起始原料,通过引入硫醚、硒醚及二硫醚键合成得到9个两亲性羟喜树碱衍生物。采用MTT法测试目标化合物对于人正常的肝细胞(L02)、肝癌细胞(HepG2)和人肺癌细胞(A549)的体外细胞毒性。结果与结论目标化合物均未见文献报道,其结构经H-NMR、^(13)C-NMR、HR-MS谱表征得以确证。其中含有硫醚及二硫醚键的羟喜树碱衍生物对L02细胞毒性显著降低,而对肿瘤细胞更具针对性。 A series of amphiphilic hydroxy-camptothecin derivatives containing sulfide, selenide and disulfide bonds were synthesized and their antitumor activities in vitro were evaluated.By a facile synthetic route, nine novel hydroxycamptothecin derivatives were obtained and their structures were confirmed by ~1H-NMR,C-NMR and HR-MS.The cytotoxicities of the target compound to human normal hepatocytes(L02),liver cancer cells(HepG2) and human lung cancer cells(A549) in vitro were tested by MTT method.The results show that the hydroxycamptothecin derivatives containing sulfide disulfide bond significantly reduce the toxicity toward L02 while remaining its toxicity toward tumor cells.
作者 黄宇 廖晓雨 高慧媛 杨鹏 HUANG Yu;LIAO Xiao-yu;GAO Hui-yuan;YANG Peng(Wuya College of Innovation henyang Pharmaceutical University,henyang 110016 China;Key Laboratory of Structure-Based Drug Design and Discovery(Shenyang Pharmaceutical University),Ministry of Education Shenyang 110016 China;School of Traditional Chinese Materia Medica,Shenyang Pharmaceutical Universiry,Shenyang 110016,China)
出处 《中国药物化学杂志》 CAS CSCD 2022年第7期511-517,共7页 Chinese Journal of Medicinal Chemistry
基金 辽宁省自然科学基金项目(20180550874)。
关键词 羟喜树碱 抗肿瘤 肿瘤微环境 氧化还原响应 合成 hydroxycamptothecin antitumor tumor microenvironment redox response antitumor synthesis
  • 相关文献

参考文献1

二级参考文献25

  • 1Verschraegen CF,Gupta E,Loyer E,et al.A phase Ⅱ clinical and pharmacological study of oral 9-nitrocamptothecin patents with refractory epithelial ovarian,tubal or peritoneal cancer[J].Anticancer Drugs,1999,10(4):375-383. 被引量:1
  • 2Adil D,Nikola V,Barbara C,et al.Phase Ⅱ Trial of Karenitecin in Patients with Malignant Melanoma:Clinical and Translational Study[J].Clin Cancer Res,2005,1 (11):3009-3016. 被引量:1
  • 3Petrangolini G,Pratesi G,De-Cesare M,et al.Antiangiogenic effects of the novel camptothecin ST1481 (gimatecan) in human tumor xenografts[J].Mol Cancer Res,2003,1 (12):863-870. 被引量:1
  • 4Mitsui I,Kumazawa E,Hirota Y,et al.A new watersoluble camptothecin derivative,DX-8951f,exhibits potent antitumor activity against human tumors in vitro and in vivo[J].Jpn J Cancer Res,1995,86(8):776-782. 被引量:1
  • 5Luzzio MJ,Besteman JM,Emerson DL,et al.Synthesis and antitumor activity of novel water soluble derivatives of camptothecin as specific inhibitors of topoisomerase Ⅰ[J].J Med Chem,1995,38(3):395 -401. 被引量:1
  • 6Dallavalle S,Merlini L,Penco S,et al.Perspectives in camptothecin development[J].Expert Opin Investig Drugs,2002,12 (6):837-844. 被引量:1
  • 7Ulukan H,Swan PW.Camptothecin:a review of their chemotherapeutical potential[J].Drugs,2002,62 (4):2 039-2 057. 被引量:1
  • 8Bhatt R,De Vries P,Tulinsky J,et al.Synthesis and in vivo antitumor activity of poly (L-glutamic acid) conjugates of 20 (S)-camptothecin[J].J Med Chem,2003,46 (1):190-193. 被引量:1
  • 9Lerchen HG,Baumgarten J.Design and optimization of 20-O-linked camptothecin glycoconjugates as anticancer agents[J].J Med Chem,2001,44(24):4 186-4 195. 被引量:1
  • 10Angenault S,Thirot S,Schmidt F,et al.Cancer chemotherapy:a SN -38(7-ethyl-10-hydroxycamptothecin) glucuronide for treatment by a PMT(prodrug monotherapy)strategy[J].Bioorg Med Chem Lett,2003,13(5):947-950. 被引量:1

共引文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部